Robert J. Wills

Dr. Robert Wills is the Chairman of Cymabay Therapeutics’ Board of Directors since October 2015 and has been a member of the Board since March, 2015.

Dr. Wills has more than 35 years of experience in the pharmaceutical industry and spent over 25 years at Johnson & Johnson, where he held positions as Senior Vice President of Global Development, Vice President of Alliance Management and member of the R&D Board of Directors. He has been responsible for the R&D pipeline and for managing strategic alliances for the Pharmaceutical Group worldwide, playing an active role in the negotiations of these alliances. Dr. Wills also served on several of the Company Boards and key decision-making committees. He began his career at Hoffmann-LaRoche where he spent 10 years in several roles of scientific responsibility.

Dr. Wills holds a B.S. in Biochemistry and an M.S. in Pharmaceutics from the University of Wisconsin, and a Ph.D. in Pharmaceutics from the University of Texas.